What is Axim Biotechnologies Inc?
develops diagnostic healthcare solutions for ophthalmological conditions.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.04M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.